Document is current
Any future updates will be listed below
-
Authors
Sigurjonsdottir, Gudbjörg
De Marchi, Tommaso
Ehinger, Anna
Hartman, Johan
Bosch, Ana
Staaf, Johan
Killander, Fredrika
Niméus, Emma
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 20 April 2023
Accepted: 2 October 2023
First Online: 10 October 2023
Declarations
:
: The Regional Ethical Review Board in Lund, Sweden, has approved the SCAN-B study (applicable registration number 2009/658, 2015/277, 2016/742, 2018/267 and 2019/01252). Written informed consent was received from all enrolled participants in the SCAN-B study and the study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests except for JH who has obtained speaker's honoraria or advisory board remunerations from Roche, Novartis, Pfizer, EliLilly, MSD, Veracyte and ExactSciences, has received institutional research support from Cepheid, Roche and Novartis and who is a co-founder and shareholder of Stratipath AB.
